Search -

Displaying 241 - 260 of 1114

Sort: Relevancy | Date

News Daily News

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Caitlin E. Cox

June 16, 2023

News Daily News

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

Michael O'Riordan

June 14, 2023

News Conference News EAS 2023

With New LDL Goalposts in FH, Combo Therapy Must Start Early

Michael O'Riordan

May 29, 2023

News Conference News ESOC 2023

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

Todd Neale

May 25, 2023

News Conference News EAS 2023

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Michael O'Riordan

May 24, 2023

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

Michael O'Riordan

May 03, 2023

News Opinion CV Team Dispatch

May 2023 News Roundup

L.A. McKeown

May 01, 2023

News Daily News

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

L.A. McKeown

April 19, 2023

News Daily News

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Michael O'Riordan

April 03, 2023

News Daily News

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Yael L. Maxwell

April 03, 2023

News Conference News ACC 2023

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

Michael O'Riordan

March 14, 2023

News Conference News ACC 2023

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Caitlin E. Cox

March 14, 2023

News Conference News ACC 2023

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Michael O'Riordan

March 13, 2023

News Conference News ACC 2023

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Yael L. Maxwell

March 13, 2023

News Conference News ACC 2023

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

Todd Neale

March 10, 2023

News Conference News ACC 2023

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Michael O'Riordan

March 10, 2023

News Conference News ACC 2023

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Michael O'Riordan

March 09, 2023

News Conference News ACC 2023

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

Yael L. Maxwell

March 07, 2023

Presentation ACC 2023

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

Presenter: Braden Manns

March 06, 2023

Advertisement

Testosterone Doesn’t Cause CV Events in High-Risk Men With Hypogonadism

Obicetrapib Effective When Added to Statins and Ezetimibe: ROSE2

With New LDL Goalposts in FH, Combo Therapy Must Start Early

ARCADIA: Apixaban No Help for ESUS Patients With Atrial Cardiopathy

Variable Response to Novel PCSK9 Inhibitor Lerodalcibep in LIBERATE-HoFH

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

Oxidized Phospholipids and Lp(a) Strongly Associated With MACE: CASABLANCA

May 2023 News Roundup

New Expert Consensus Papers Aim to Boost Management, Outcomes in HFpEF

Moderate-Intensity Exercise Possible For Patients With Statin Side Effects

Ezetimibe Plus Moderate-Dose Statins May Aid Compliance in the Elderly

Diabetic Patients in Middle East, Africa Overburdened by ASCVD

CRP More Predictive of Future Events Than LDL in Statin-Treated Patients

Treat to Target or With Intensity? Both Statin Tactics Cut MACE: LODESTAR

Tailored Alerts Up High-Intensity Statin Prescribing: PCDS Statin

Oral PCSK9 Inhibitor Reduces LDL Cholesterol in Phase IIb Study

MASTER@HEART: Long-term Endurance Athletes Not Immune to Atherosclerosis

Viability Testing Fails to Find HF Patients Who’d Benefit From PCI in REVIVED-BCIS2

Multifaceted Approach to COORDINATE Diabetes Care Improves GDMT

A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content